MCKEW JOHN C. (Chief Scientific Officer) sold 21.2% of their position (3.41K shares) of LUMOS PHARMA, INC. on the open market
Open‑market sale worth $6.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2024ACC: 0001126234-24-000094
Officer· Chief Scientific Officer
Since Mar 2020
-3.41K
Net shares
Net seller
$6.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.41K
Price / share
$1.89
Trade value
$6.43K
% of position
21.2%
8/6/2024
16.06K→12.65K
Total
Net shares
−3.41K
Net value
-$6.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2024 | S · Sale | −3.41K | $1.89 | $6.43K | 21.2% | 16.06K | 12.65K |
| Total | −3.41K | -$6.43K | ||||||
Derivative Transactions0
No derivative transactions reported